ST. LOUIS, Dec. 15, 2010 (GLOBE NEWSWIRE) -- Murphy Analytics (MA) has updated coverage on True 2 Beauty Inc. (Other OTC:TRTB), a California based manufacturer and distributor of sexual enhancement pills and liquids. The Update Report contains a detailed discussion of TRTB recent business developments and objectives, market trends, macroeconomic data and indicators, and risks. The Update Report is available at http://www.murphyanalytics.com/uploads/TRTB_Update.
Analyst Patrick J. Murphy, CFA notes in the report: "Announced 12/13/10, TRTB's distribution agreement with Kretek International, Inc. ("Kretek") provides the Company with access to a leading distributor of specialty general merchandise and tobacco products to convenience stores and other retail channels in the U.S. and Canada...TRTB's focus for 2011 includes consolidation of operations at the new facility, commencement of a robust marketing campaign, and increasing production capacity. Also as noted by Mr. Hbaiu in the Kretek announcement, the Company expects to report in more detail on revenue growth and forecasted revenue and profitability, beginning with the Company's first conference call in January 2011. By obtaining expanded production facilities and equipment, and by leveraging Kretek's expansive distribution network, TRTB's focus on production, distribution and marketing is positioning the Company for what looks like a significant growth opportunity."
About Murphy Analytics
Murphy Analytics is an independent investment research firm providing coverage of microcap and smallcap stocks. Utilizing institutional caliber, fundamental, bottom-up analysis, Murphy Analytics helps investors make informed investment decisions about equities without extensive analyst coverage, with a focus on small-cap and micro-cap public stocks. Murphy Analytics LLC is owned by Patrick J. Murphy, who has over 15 years of capital markets experience, providing institutional investment and transaction analysis across a range of asset classes including microcap equities, commercial real estate debt and equity, municipal derivatives and public finance, venture capital, fixed income, CMBS and mortgage REIT's.
Disclosure: Murphy Analytics (MA) was compensated $12,000 in advance of the publication of an Initiation Report dated 10/10/10 and this Update report. Neither MA nor the analyst owns or trades the shares of covered companies. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. MA provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. This report is neither a solicitation to buy nor an offer to sell securities and is to be used for informational purposes only and should not be used as basis for investment decisions. MA is not an investment advisor or broker/dealer and this report does not provide investment advice.